The Gross Margin of CanSino Biologics Inc (688185.SS) is 69.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 69.60% |
2023-12-31 | -124.27% |
2022-12-31 | -17.76% |
2021-12-31 | 69.82% |
2020-12-31 | 25.57% |